[archlight]

well we already have this protein based vaccine Novavax 2373 with cross immune response based on prototype developed 2.5 years ago. because it not only has full representation of spike protein (unlike mRNA taking shortcut to represent S protein) but also cleavage site which is omicron BA5 immune escape from. However big pharma politics slowed down the approval, purpose delaying US P3 trial, introducing CMC requirement 1 month before formally submitting the application. Novavax 2373 has shown superb efficacy results since Jan 2021 UK trial and follow up study showed long term protection (titers half life 9months compared to mRNA 3months). no myocarditis risk. still FDA only approved it now half year after submission blaming the company's manufacture issue while it has been distributing hundred of millions of doses worldwide mRNA is not vaccine. it is only genetic therapy